CN111574413A - A kind of preparation method of sulfonyl amidine with 2-aminomethylpyridine and DMF-DMA as amine source - Google Patents
A kind of preparation method of sulfonyl amidine with 2-aminomethylpyridine and DMF-DMA as amine source Download PDFInfo
- Publication number
- CN111574413A CN111574413A CN202010510716.1A CN202010510716A CN111574413A CN 111574413 A CN111574413 A CN 111574413A CN 202010510716 A CN202010510716 A CN 202010510716A CN 111574413 A CN111574413 A CN 111574413A
- Authority
- CN
- China
- Prior art keywords
- dma
- dmf
- sulfonyl
- aminomethylpyridine
- reaction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- WOXFMYVTSLAQMO-UHFFFAOYSA-N 2-Pyridinemethanamine Chemical compound NCC1=CC=CC=N1 WOXFMYVTSLAQMO-UHFFFAOYSA-N 0.000 title claims abstract description 48
- DFEXVBOMMIJOAW-UHFFFAOYSA-N carbamimidoylsulfonylmethanimidamide Chemical compound NC(=N)S(=O)(=O)C(N)=N DFEXVBOMMIJOAW-UHFFFAOYSA-N 0.000 title claims abstract description 30
- 150000001412 amines Chemical class 0.000 title claims abstract description 19
- 238000002360 preparation method Methods 0.000 title claims abstract description 15
- REPVNSJSTLRQEQ-UHFFFAOYSA-N n,n-dimethylacetamide;n,n-dimethylformamide Chemical compound CN(C)C=O.CN(C)C(C)=O REPVNSJSTLRQEQ-UHFFFAOYSA-N 0.000 title claims abstract 20
- 238000006243 chemical reaction Methods 0.000 claims abstract description 82
- YBBRCQOCSYXUOC-UHFFFAOYSA-N sulfuryl dichloride Chemical compound ClS(Cl)(=O)=O YBBRCQOCSYXUOC-UHFFFAOYSA-N 0.000 claims abstract description 24
- 239000003054 catalyst Substances 0.000 claims abstract description 10
- 238000012805 post-processing Methods 0.000 claims abstract description 4
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 63
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 48
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical group CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 30
- YYROPELSRYBVMQ-UHFFFAOYSA-N 4-toluenesulfonyl chloride Chemical group CC1=CC=C(S(Cl)(=O)=O)C=C1 YYROPELSRYBVMQ-UHFFFAOYSA-N 0.000 claims description 18
- 239000002904 solvent Substances 0.000 claims description 17
- NWFNSTOSIVLCJA-UHFFFAOYSA-L copper;diacetate;hydrate Chemical group O.[Cu+2].CC([O-])=O.CC([O-])=O NWFNSTOSIVLCJA-UHFFFAOYSA-L 0.000 claims description 12
- 150000007530 organic bases Chemical class 0.000 claims description 11
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 claims description 9
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 8
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 8
- XTVVROIMIGLXTD-UHFFFAOYSA-N copper(II) nitrate Chemical compound [Cu+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O XTVVROIMIGLXTD-UHFFFAOYSA-N 0.000 claims description 7
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 6
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 6
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 claims description 6
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 claims description 6
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 claims description 5
- ORTQZVOHEJQUHG-UHFFFAOYSA-L copper(II) chloride Chemical compound Cl[Cu]Cl ORTQZVOHEJQUHG-UHFFFAOYSA-L 0.000 claims description 5
- 125000006527 (C1-C5) alkyl group Chemical group 0.000 claims description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 4
- QTMDXZNDVAMKGV-UHFFFAOYSA-L copper(ii) bromide Chemical compound [Cu+2].[Br-].[Br-] QTMDXZNDVAMKGV-UHFFFAOYSA-L 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 4
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 4
- PVJZBZSCGJAWNG-UHFFFAOYSA-N 2,4,6-trimethylbenzenesulfonyl chloride Chemical compound CC1=CC(C)=C(S(Cl)(=O)=O)C(C)=C1 PVJZBZSCGJAWNG-UHFFFAOYSA-N 0.000 claims description 3
- KMMHZIBWCXYAAH-UHFFFAOYSA-N 4-bromobenzenesulfonyl chloride Chemical compound ClS(=O)(=O)C1=CC=C(Br)C=C1 KMMHZIBWCXYAAH-UHFFFAOYSA-N 0.000 claims description 3
- YEZADZMMVHWFIY-UHFFFAOYSA-N 4-tert-butylbenzenesulfonyl chloride Chemical compound CC(C)(C)C1=CC=C(S(Cl)(=O)=O)C=C1 YEZADZMMVHWFIY-UHFFFAOYSA-N 0.000 claims description 3
- 229910021589 Copper(I) bromide Inorganic materials 0.000 claims description 3
- 229910021591 Copper(I) chloride Inorganic materials 0.000 claims description 3
- CSKNSYBAZOQPLR-UHFFFAOYSA-N benzenesulfonyl chloride Chemical compound ClS(=O)(=O)C1=CC=CC=C1 CSKNSYBAZOQPLR-UHFFFAOYSA-N 0.000 claims description 3
- OXBLHERUFWYNTN-UHFFFAOYSA-M copper(I) chloride Chemical compound [Cu]Cl OXBLHERUFWYNTN-UHFFFAOYSA-M 0.000 claims description 3
- NKNDPYCGAZPOFS-UHFFFAOYSA-M copper(i) bromide Chemical compound Br[Cu] NKNDPYCGAZPOFS-UHFFFAOYSA-M 0.000 claims description 3
- 229940045803 cuprous chloride Drugs 0.000 claims description 3
- 229910021590 Copper(II) bromide Inorganic materials 0.000 claims description 2
- 125000003545 alkoxy group Chemical group 0.000 claims description 2
- 229960003280 cupric chloride Drugs 0.000 claims description 2
- 125000005843 halogen group Chemical group 0.000 claims description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 2
- 239000007810 chemical reaction solvent Substances 0.000 claims 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims 1
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims 1
- 150000003053 piperidines Chemical class 0.000 claims 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 abstract description 57
- 239000013067 intermediate product Substances 0.000 abstract description 28
- 239000000047 product Substances 0.000 abstract description 17
- 238000000034 method Methods 0.000 abstract description 16
- 229940124530 sulfonamide Drugs 0.000 abstract description 6
- 238000003786 synthesis reaction Methods 0.000 abstract description 5
- 230000015572 biosynthetic process Effects 0.000 abstract description 3
- 125000000565 sulfonamide group Chemical group 0.000 abstract 1
- ZSXGLVDWWRXATF-UHFFFAOYSA-N N,N-dimethylformamide dimethyl acetal Chemical compound COC(OC)N(C)C ZSXGLVDWWRXATF-UHFFFAOYSA-N 0.000 description 32
- 239000008367 deionised water Substances 0.000 description 26
- 229910021641 deionized water Inorganic materials 0.000 description 26
- 238000004128 high performance liquid chromatography Methods 0.000 description 26
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 26
- -1 Amidine compounds Chemical class 0.000 description 24
- 239000000843 powder Substances 0.000 description 24
- 239000007787 solid Substances 0.000 description 19
- 239000012044 organic layer Substances 0.000 description 17
- 238000004440 column chromatography Methods 0.000 description 15
- 239000007788 liquid Substances 0.000 description 15
- 238000005481 NMR spectroscopy Methods 0.000 description 13
- 238000002844 melting Methods 0.000 description 12
- 230000008018 melting Effects 0.000 description 12
- 238000002390 rotary evaporation Methods 0.000 description 12
- UVXVYQURGLFLAJ-UHFFFAOYSA-N 4-methyl-n-(pyridin-2-ylmethyl)benzenesulfonamide Chemical compound C1=CC(C)=CC=C1S(=O)(=O)NCC1=CC=CC=N1 UVXVYQURGLFLAJ-UHFFFAOYSA-N 0.000 description 11
- 239000000543 intermediate Substances 0.000 description 11
- 239000005457 ice water Substances 0.000 description 10
- 238000005160 1H NMR spectroscopy Methods 0.000 description 6
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 6
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 6
- 229910052739 hydrogen Inorganic materials 0.000 description 6
- 239000001257 hydrogen Substances 0.000 description 6
- 238000001228 spectrum Methods 0.000 description 5
- 150000003456 sulfonamides Chemical class 0.000 description 5
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 4
- CTSLXHKWHWQRSH-UHFFFAOYSA-N oxalyl chloride Chemical compound ClC(=O)C(Cl)=O CTSLXHKWHWQRSH-UHFFFAOYSA-N 0.000 description 4
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- PQLVXDKIJBQVDF-UHFFFAOYSA-N acetic acid;hydrate Chemical compound O.CC(O)=O PQLVXDKIJBQVDF-UHFFFAOYSA-N 0.000 description 3
- 229910052802 copper Inorganic materials 0.000 description 3
- 239000010949 copper Substances 0.000 description 3
- 239000012954 diazonium Substances 0.000 description 3
- SPEUIVXLLWOEMJ-UHFFFAOYSA-N 1,1-dimethoxyethane Chemical compound COC(C)OC SPEUIVXLLWOEMJ-UHFFFAOYSA-N 0.000 description 2
- DTJVECUKADWGMO-UHFFFAOYSA-N 4-methoxybenzenesulfonyl chloride Chemical compound COC1=CC=C(S(Cl)(=O)=O)C=C1 DTJVECUKADWGMO-UHFFFAOYSA-N 0.000 description 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 2
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 2
- RAHZWNYVWXNFOC-UHFFFAOYSA-N Sulphur dioxide Chemical compound O=S=O RAHZWNYVWXNFOC-UHFFFAOYSA-N 0.000 description 2
- 150000001408 amides Chemical class 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 150000001989 diazonium salts Chemical class 0.000 description 2
- 125000004433 nitrogen atom Chemical group N* 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- RCBXQALFHNNNPJ-UHFFFAOYSA-N 2,4,6-trimethyl-n-(pyridin-2-ylmethyl)benzenesulfonamide Chemical compound CC1=CC(C)=CC(C)=C1S(=O)(=O)NCC1=CC=CC=N1 RCBXQALFHNNNPJ-UHFFFAOYSA-N 0.000 description 1
- BSKHPKMHTQYZBB-UHFFFAOYSA-N 2-methylpyridine Chemical compound CC1=CC=CC=N1 BSKHPKMHTQYZBB-UHFFFAOYSA-N 0.000 description 1
- 125000006479 2-pyridyl methyl group Chemical group [H]C1=C([H])C([H])=C([H])C(=N1)C([H])([H])* 0.000 description 1
- BXJPCKCXPGODGR-UHFFFAOYSA-N 4-bromo-n-(pyridin-2-ylmethyl)benzenesulfonamide Chemical compound C1=CC(Br)=CC=C1S(=O)(=O)NCC1=CC=CC=N1 BXJPCKCXPGODGR-UHFFFAOYSA-N 0.000 description 1
- QXCTXPHWAZBNCY-UHFFFAOYSA-N 4-methoxy-n-(pyridin-2-ylmethyl)benzenesulfonamide Chemical compound C1=CC(OC)=CC=C1S(=O)(=O)NCC1=CC=CC=N1 QXCTXPHWAZBNCY-UHFFFAOYSA-N 0.000 description 1
- FSBFQFMQMMIEOQ-UHFFFAOYSA-N 4-tert-butyl-n-(pyridin-2-ylmethyl)benzenesulfonamide Chemical compound C1=CC(C(C)(C)C)=CC=C1S(=O)(=O)NCC1=CC=CC=N1 FSBFQFMQMMIEOQ-UHFFFAOYSA-N 0.000 description 1
- XVMSFILGAMDHEY-UHFFFAOYSA-N 6-(4-aminophenyl)sulfonylpyridin-3-amine Chemical compound C1=CC(N)=CC=C1S(=O)(=O)C1=CC=C(N)C=N1 XVMSFILGAMDHEY-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 1
- 150000001540 azides Chemical class 0.000 description 1
- ODWXUNBKCRECNW-UHFFFAOYSA-M bromocopper(1+) Chemical compound Br[Cu+] ODWXUNBKCRECNW-UHFFFAOYSA-M 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229960001701 chloroform Drugs 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 150000001879 copper Chemical class 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 239000002360 explosive Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000000417 fungicide Substances 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000000077 insect repellent Substances 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- AUHZEENZYGFFBQ-UHFFFAOYSA-N mesitylene Substances CC1=CC(C)=CC(C)=C1 AUHZEENZYGFFBQ-UHFFFAOYSA-N 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- ATNMJYCSSCNVMR-UHFFFAOYSA-N n-(pyridin-2-ylmethyl)benzenesulfonamide Chemical compound C=1C=CC=CC=1S(=O)(=O)NCC1=CC=CC=N1 ATNMJYCSSCNVMR-UHFFFAOYSA-N 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 239000012450 pharmaceutical intermediate Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 description 1
- HSVFKFNNMLUVEY-UHFFFAOYSA-N sulfuryl diazide Chemical compound [N-]=[N+]=NS(=O)(=O)N=[N+]=[N-] HSVFKFNNMLUVEY-UHFFFAOYSA-N 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 150000003512 tertiary amines Chemical class 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
- C07C303/36—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids
- C07C303/40—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids by reactions not involving the formation of sulfonamide groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/40—Acylated substituent nitrogen atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pyridine Compounds (AREA)
Abstract
本发明公开了一种2‑氨甲基吡啶与DMF‑DMA作为胺源的磺酰脒的制备方法,包括以下步骤:首先,以磺酰氯与2‑氨甲基吡啶反应,得中间产物;然后,中间产物与DMF‑DMA在催化剂存在下,于60~100℃反应,然后降至室温,反应液用乙酸乙酯萃取,分层,干燥后浓缩得到目标产物磺酰脒。本发明方法实现了二级磺酰胺与DMF‑DMA的反应,拓展了磺酰脒的合成路径。合成反应操作简单、条件温和、后处理方便,所得中间产物及产品的纯度和收率高。The invention discloses a preparation method of sulfonyl amidine with 2-aminomethyl pyridine and DMF-DMA as amine sources, comprising the following steps: firstly, reacting sulfonyl chloride with 2-aminomethyl pyridine to obtain an intermediate product; then , the intermediate product and DMF-DMA are reacted at 60-100 ℃ in the presence of a catalyst, and then cooled to room temperature, the reaction solution is extracted with ethyl acetate, layered, dried and concentrated to obtain the target product sulfonyl amidine. The method of the invention realizes the reaction of the secondary sulfonamide and DMF-DMA, and expands the synthesis path of the sulfonyl amidine. The synthesis reaction has simple operation, mild conditions, convenient post-processing, and the obtained intermediate products and products have high purity and yield.
Description
技术领域technical field
本发明属于有机中间体合成领域,具体涉及一种2-氨甲基吡啶与N,N-二甲基甲酰胺二甲基缩醛(DMF-DMA)作为胺源的磺酰脒的制备方法。The invention belongs to the field of organic intermediate synthesis, in particular to a method for preparing a sulfonyl amidine using 2-aminomethylpyridine and N,N-dimethylformamide dimethyl acetal (DMF-DMA) as amine sources.
背景技术Background technique
脒类化合物是一类重要的含氮有机物。随着N原子上取代基位置和数量变化,脒类化合物及其衍生物的物化性质也随之改变,因而其被应用于生产生活的方方面面。脒类化合物可被用于合成表面活性剂、染料、医疗药剂、杀菌剂、驱虫剂及一系列重要化合物的中间体。脒类化合物存在于许多具有生物活性的天然化合物中,故被认为是重要的医药中间体。Amidine compounds are an important class of nitrogen-containing organic compounds. With the change of the position and number of substituents on the N atom, the physicochemical properties of amidine compounds and their derivatives also change, so they are used in all aspects of production and life. Amidine compounds can be used to synthesize surfactants, dyes, medical agents, fungicides, insect repellants and intermediates for a series of important compounds. Amidine compounds exist in many natural compounds with biological activity, so they are considered as important pharmaceutical intermediates.
当碳氮双键中的N原子与磺酰基相连时,脒类化合物往往具有更高的生物活性和药理作用,因而备受科学界和产业界的关注。When the N atom in the carbon-nitrogen double bond is connected to a sulfonyl group, the amidine compounds tend to have higher biological activity and pharmacological effects, and thus have attracted much attention from the scientific and industrial circles.
目前合成磺酰脒类化合物常使用重氮盐或叠氮化合物作为胺源。如利用四氟硼酸重氮盐和磺酰胺、乙腈在1,2-二氯乙烷中反应生成磺酰脒;使用磺酰叠氮与叔胺在铜盐和四氯化碳催化下也可制得一系列磺酰脒。但重氮盐和叠氮化合物普遍不稳定、易爆炸的性质限制了此类方法的普适性。At present, diazonium salts or azide compounds are often used as amine sources for the synthesis of sulfonyl amidines. For example, using tetrafluoroborate diazonium salt and sulfonamide, acetonitrile in 1,2-dichloroethane to generate sulfonyl amidine; using sulfonyl azide and tertiary amine under the catalysis of copper salt and carbon tetrachloride can also be prepared A series of sulfonyl amidines were obtained. However, the generally unstable and explosive properties of diazonium salts and azides limit the applicability of such methods.
在采用简单的磺酰胺与酰胺作为胺源时,需要草酰氯或二氯亚砜等与酰胺制成维尔斯迈尔试剂才能顺利进行脱水反应得到磺酰脒。其不足之处在于使用草酰氯需过量,使用二氯亚砜则会产生二氧化硫气体。When simple sulfonamide and amide are used as amine sources, oxalyl chloride or thionyl chloride, etc. and amide are required to make Wilsmeier reagent to successfully conduct dehydration reaction to obtain sulfonyl amidine. The disadvantage is that the use of oxalyl chloride needs to be excessive, and the use of thionyl chloride will generate sulfur dioxide gas.
发明内容SUMMARY OF THE INVENTION
本发明克服了上述路线胺源单一的缺陷,提出了一种环境较为友好的磺酰脒类化合物的制备方法。即通过2-氨甲基吡啶与对甲苯磺酰氯反应制得N-(2-吡啶甲基)对甲苯磺酰胺后,实现二级磺酰胺与DMF-DMA(N,N-二甲基甲酰胺二甲基缩醛)反应制备对甲苯磺酰脒。The present invention overcomes the defect of single amine source of the above route, and proposes a preparation method of sulfonyl amidine compounds which is more environmentally friendly. That is, after the reaction of 2-aminomethylpyridine and p-toluenesulfonyl chloride to prepare N-(2-pyridylmethyl)-p-toluenesulfonamide, the secondary sulfonamide and DMF-DMA (N,N-dimethylformamide are realized) dimethyl acetal) to prepare p-toluenesulfonyl amidine.
为解决上述技术问题,本发明提供的技术方案如下:In order to solve the above-mentioned technical problems, the technical solutions provided by the present invention are as follows:
一种2-氨甲基吡啶与DMF-DMA作为胺源的磺酰脒的制备方法,包括:磺酰氯与2-氨甲基吡啶在有机碱存在下,反应得到的中间体再与DMF-DMA在催化剂存在下反应得到磺酰脒;A preparation method of sulfonyl amidine with 2-aminomethyl pyridine and DMF-DMA as amine source, comprising: sulfonyl chloride and 2-aminomethyl pyridine in the presence of an organic base, reacting the intermediate obtained with DMF-DMA In the presence of a catalyst, the reaction obtains the sulfonyl amidine;
所述磺酰氯、中间体以及磺酰脒的结构分别如下式所示:The structures of the sulfonyl chloride, the intermediate and the sulfonyl amidine are respectively shown in the following formulas:
R1选自C1-C5的烷基;C1-C5的烷氧基;卤素原子;氢原子。R 1 is selected from a C1-C5 alkyl group; a C1-C5 alkoxy group; a halogen atom; a hydrogen atom.
R2,R3各自独立的选自C1-C5的烷基;氢原子。R 2 and R 3 are each independently selected from C1-C5 alkyl groups; hydrogen atoms.
作为优选,所述R1选自叔丁基、甲基、乙基、甲氧基、乙氧基,溴原子、氢原子;所述R2,R3各自独立的选自甲基、氢原子。Preferably, the R 1 is selected from tert-butyl group, methyl group, ethyl group, methoxy group, ethoxy group, bromine atom and hydrogen atom; the R 2 and R 3 are independently selected from methyl group and hydrogen atom. .
作为优选,一种2-氨甲基吡啶与DMF-DMA作为胺源的磺酰脒的制备方法,包括:As preferably, a kind of preparation method of the sulfonyl amidine of 2-aminomethylpyridine and DMF-DMA as amine source, comprises:
(1)向溶剂I中加入磺酰氯,溶解得到磺酰氯溶液;将2-氨甲基吡啶和有机碱的混合物滴加到上述磺酰氯溶液中,反应完毕,经后处理得中间体;(1) in
(2)将步骤(1)得到的中间体、DMF-DMA、催化剂与溶剂II混合,反应,后处理得磺酰脒。(2) Mix the intermediate, DMF-DMA, catalyst and solvent II obtained in step (1), react, and post-process to obtain the sulfonyl amidine.
具体讲:本发明以2-氨甲基吡啶、磺酰氯为原料,制备磺酰脒,包括以下步骤:Specifically: the present invention uses 2-aminomethylpyridine and sulfonyl chloride as raw materials to prepare sulfonyl amidine, comprising the following steps:
(1)向一定量的溶剂I中加入磺酰氯,并于室温条件下搅拌溶解;在另一反应瓶中加入2-氨甲基吡啶和有机碱,再缓慢滴加到上述磺酰氯溶液中,反应4~8h;反应完毕,经过旋蒸、冰水洗涤、过滤、烘干得中间体;(1) in a certain amount of solvent I, add sulfonyl chloride, and stir and dissolve at room temperature; In another reaction flask, add 2-aminomethylpyridine and organic base, then slowly drip into the above-mentioned sulfonyl chloride solution, The reaction is carried out for 4 to 8 hours; after the reaction is completed, the intermediate is obtained by rotary evaporation, washing with ice water, filtration and drying;
(2)将步骤(1)得到的中间体加入到溶剂II中,加入DMF-DMA,催化剂,在60~100℃下反应6~10h,降至室温后,反应液用乙酸乙酯萃取,分层,干燥,浓缩,得目标产物磺酰脒。(2) Add the intermediate obtained in step (1) into solvent II, add DMF-DMA, a catalyst, and react at 60-100° C. for 6-10 hours. After cooling to room temperature, the reaction solution is extracted with ethyl acetate, and the mixture is separated. layer, dried and concentrated to obtain the target product sulfonyl amidine.
以R为甲基、甲氧基、叔丁基、溴原子或氢原子,R2、R3为甲基或氢原子为例,上述反应过程如下式所示:Taking R as methyl group, methoxyl group, tert-butyl group, bromine atom or hydrogen atom, and R 2 and R 3 as methyl group or hydrogen atom as example, the above reaction process is shown in the following formula:
作为优选,所用磺酰氯为对甲基苯磺酰氯、对甲氧基苯磺酰氯、对叔丁基苯磺酰氯、苯磺酰氯、对溴基苯磺酰氯或均三甲基苯磺酰氯。Preferably, the used sulfonyl chloride is p-toluenesulfonyl chloride, p-methoxybenzenesulfonyl chloride, p-tert-butylbenzenesulfonyl chloride, benzenesulfonyl chloride, p-bromobenzenesulfonyl chloride or mesitylenesulfonyl chloride.
为在第一步反应中得到更多的中间产品,作为优选,2-氨甲基吡啶,磺酰氯,有机碱的摩尔比为1:1~2:1~2;作为进一步优选,2-氨甲基吡啶,磺酰氯,有机碱的摩尔比为1:1~1.3:1.5~1.7。作为优选,溶剂I和2-氨甲基吡啶的重量比为30~50:1。In order to obtain more intermediate products in the first step reaction, preferably, the molar ratio of 2-aminomethylpyridine, sulfonyl chloride, and organic base is 1:1~2:1~2; as a further preference, 2-aminomethylpyridine The molar ratio of methylpyridine, sulfonyl chloride and organic base is 1:1-1.3:1.5-1.7. Preferably, the weight ratio of solvent I and 2-aminomethylpyridine is 30-50:1.
磺酰氯与2-氨甲基吡啶反应时(或步骤(1)中),使用的溶剂(或溶剂I)优选为二氯甲烷、1,2-二氯乙烷、四氢呋喃中的一种。作为优选,磺酰氯与2-氨甲基吡啶反应时(或步骤(1)中),使用的溶剂为二氯甲烷。When the sulfonyl chloride is reacted with 2-aminomethylpyridine (or in step (1)), the solvent (or solvent I) used is preferably one of dichloromethane, 1,2-dichloroethane and tetrahydrofuran. Preferably, when the sulfonyl chloride is reacted with 2-aminomethylpyridine (or in step (1)), the solvent used is dichloromethane.
作为优选,所述的有机碱为三乙胺、三甲胺、吡啶、哌啶。作为进一步优选,所述有机碱为三乙胺。作为进一步优选,所述2-氨甲基吡啶,磺酰氯,三乙胺的摩尔比为1:1~1.3:1.5~1.7。Preferably, the organic base is triethylamine, trimethylamine, pyridine and piperidine. As a further preference, the organic base is triethylamine. As a further preference, the molar ratio of the 2-aminomethylpyridine, the sulfonyl chloride and the triethylamine is 1:1-1.3:1.5-1.7.
中间体与DMF-DMA反应时(或步骤(2)),所用溶剂(或者溶剂II)为乙二醇、异丙醇、正丙醇、正丁醇、二乙二醇中的一种或多种。作为进一步优选,所述溶剂(或溶剂II)为乙二醇。When the intermediate reacts with DMF-DMA (or step (2)), the solvent used (or solvent II) is one or more of ethylene glycol, isopropanol, n-propanol, n-butanol, and diethylene glycol. kind. As a further preference, the solvent (or solvent II) is ethylene glycol.
中间体与DMF-DMA反应时(或步骤(2)),所用的催化剂为一水合醋酸铜、氯化亚铜、氯化铜、硝酸铜、溴化铜、溴化亚铜。进一步优选为一水合醋酸铜。When the intermediate reacts with DMF-DMA (or step (2)), the catalyst used is copper acetate monohydrate, cuprous chloride, cupric chloride, cupric nitrate, cupric bromide, and cuprous bromide. More preferably, it is copper acetate monohydrate.
为尽可能多地得到产品,第二步反应中所用中间产物与催化剂的摩尔比为1:0.02~0.1,所用溶剂与中间产物的重量比为20~40:1,所用DMF-DMA与中间产物的重量比为5~30:1,进一步优选为所述DMF-DMA与中间产物的重量比为10~20:1。作为更进一步优选,所述DMF-DMA与中间产物的重量比为10~15:1。In order to obtain as many products as possible, the molar ratio of the intermediate product used in the second step reaction to the catalyst is 1:0.02~0.1, the weight ratio of the solvent used to the intermediate product is 20~40:1, the used DMF-DMA and the intermediate product are The weight ratio of the DMF-DMA to the intermediate product is 5-30:1, more preferably, the weight ratio of the DMF-DMA to the intermediate product is 10-20:1. As a further preference, the weight ratio of the DMF-DMA to the intermediate product is 10-15:1.
作为优选,所述中间体与DMF-DMA反应的溶剂为乙二醇;所述催化剂为一水合醋酸铜。反应温度为60~100℃,反应时间为6~10小时。Preferably, the solvent for the reaction between the intermediate and DMF-DMA is ethylene glycol; the catalyst is copper acetate monohydrate. The reaction temperature is 60-100°C, and the reaction time is 6-10 hours.
本发明与现有技术相比具有以下优点:Compared with the prior art, the present invention has the following advantages:
1.第一步合成中间产物的反应操作简单、条件温和、后处理方便,所得中间产物的纯度和收率高。1. The reaction operation of the first step to synthesize the intermediate product is simple, the conditions are mild, the post-processing is convenient, and the obtained intermediate product has high purity and yield.
2.利用2-吡啶甲基的特殊性,实现了二级磺酰胺与DMF-DMA的反应,进一步丰富了合成磺酰脒的方法。2. Utilizing the particularity of 2-pyridylmethyl, the reaction between secondary sulfonamide and DMF-DMA was realized, which further enriched the method for synthesizing sulfonyl amidine.
综上所述,本发明方法实现了二级磺酰胺与DMF-DMA的反应,拓展了磺酰脒的合成路径。合成反应操作简单、条件温和、后处理方便,所得中间产物及产品的纯度和收率高。To sum up, the method of the present invention realizes the reaction of the secondary sulfonamide and DMF-DMA, and expands the synthetic route of the sulfonyl amidine. The synthesis reaction has simple operation, mild conditions, convenient post-processing, and the obtained intermediate products and products have high purity and yield.
附图说明Description of drawings
图1为本发明具体实施例1中所得产品对甲苯磺酰脒的氢核磁谱图(1H-NMR),核磁数据如下:1H NMR(500MHz,DMSO-d6)δ8.19(s,1H),7.64(d,J=8.2Hz,2H),7.32(d,J=7.9Hz,2H),3.13(s,3H),2.88(s,3H),2.35(s,3H)。Fig. 1 is the hydrogen nuclear magnetic spectrum ( 1 H-NMR) of the product p-toluenesulfonyl amidine obtained in
图2为本发明具体实施例16中所得产品对叔丁基苯磺酰脒的氢核磁谱图(1H-NMR),核磁数据如下:1H NMR(500MHz,Chloroform-d)δ8.15(s,1H),7.82(d,J=6.6Hz,2H),7.47(d,J=8.8Hz,2H),3.12(s,3H),3.02(s,3H),1.33(s,9H)。Fig. 2 is the hydrogen nuclear magnetic spectrum ( 1 H-NMR) of the product p-tert-butylbenzenesulfonyl amidine obtained in specific embodiment 16 of the present invention, and the nuclear magnetic data are as follows: 1 H NMR (500MHz, Chloroform-d) δ8.15 ( s, 1H), 7.82 (d, J=6.6 Hz, 2H), 7.47 (d, J=8.8 Hz, 2H), 3.12 (s, 3H), 3.02 (s, 3H), 1.33 (s, 9H).
图3为本发明具体实施例17中所得产品对甲氧基苯磺酰脒的氢核磁谱图(1H-NMR),核磁数据如下:1H NMR(500MHz,Chloroform-d)δ8.12(s,1H),7.81(d,J=8.9Hz,2H),6.91(d,J=8.9Hz,2H),3.84(s,3H),3.12(s,3H),3.01(s,3H)。Fig. 3 is the hydrogen nuclear magnetic spectrum ( 1 H-NMR) of the product p-methoxybenzenesulfonyl amidine obtained in specific embodiment 17 of the present invention, and the nuclear magnetic data are as follows: 1 H NMR (500MHz, Chloroform-d) δ8.12 ( s, 1H), 7.81 (d, J=8.9Hz, 2H), 6.91 (d, J=8.9Hz, 2H), 3.84 (s, 3H), 3.12 (s, 3H), 3.01 (s, 3H).
图4为本发明具体实施例18中所得产品苯磺酰脒的氢核磁谱图(1H-NMR),核磁数据如下:1H NMR(500MHz,Chloroform-d)δ8.15(s,1H),7.89(d,J=7.1Hz,2H),7.57–7.39(m,3H),3.13(s,3H),3.02(s,3H)。Fig. 4 is the hydrogen nuclear magnetic spectrum ( 1 H-NMR) of the product benzenesulfonyl amidine obtained in the specific embodiment of the present invention, and the nuclear magnetic data are as follows: 1 H NMR (500MHz, Chloroform-d) δ8.15 (s, 1H) , 7.89 (d, J=7.1 Hz, 2H), 7.57–7.39 (m, 3H), 3.13 (s, 3H), 3.02 (s, 3H).
图5为本发明具体实施例19中所得产品对溴基苯磺酰脒的氢核磁谱图(1H-NMR),核磁数据如下:1H NMR(500MHz,Chloroform-d)δ8.13(s,1H),7.75(d,J=8.6Hz,2H),7.60(d,J=8.6Hz,2H),3.15(s,3H),3.02(s,3H)。Fig. 5 is the hydrogen nuclear magnetic spectrum ( 1 H-NMR) of the product p-bromobenzenesulfonyl amidine obtained in specific embodiment 19 of the present invention, and the nuclear magnetic data are as follows: 1 H NMR (500MHz, Chloroform-d) δ8.13 (s , 1H), 7.75 (d, J=8.6 Hz, 2H), 7.60 (d, J=8.6 Hz, 2H), 3.15 (s, 3H), 3.02 (s, 3H).
图6、图7分别为本发明具体实施例20中所得产品均三甲基苯磺酰脒的氢核磁谱图(1H-NMR)和碳核磁谱图,核磁数据如下:1H NMR(500MHz,Chloroform-d)δ8.11(s,1H),6.91(s,2H),3.09(s,3H),2.99(s,3H),2.68(s,6H),2.27(s,3H)。13C NMR(126MHz,Chloroform-d)δ158.46,141.22,138.43,136.51,131.46,41.28,35.42,23.02,20.89。Fig. 6, Fig. 7 are respectively the hydrogen nuclear magnetic spectrogram ( 1 H-NMR) and carbon nuclear magnetic spectrogram of the obtained product mesitylene sulfonyl amidine in the specific embodiment of the present invention 20, and the nuclear magnetic data are as follows: 1 H NMR (500MHz) , Chloroform-d) δ 8.11(s, 1H), 6.91(s, 2H), 3.09(s, 3H), 2.99(s, 3H), 2.68(s, 6H), 2.27(s, 3H). 13 C NMR (126 MHz, Chloroform-d) δ 158.46, 141.22, 138.43, 136.51, 131.46, 41.28, 35.42, 23.02, 20.89.
具体实施方式Detailed ways
实施例1Example 1
在干燥的反应瓶中加入1.14g(6mmol)对甲苯磺酰氯及10mL二氯甲烷,室温下搅拌溶解,缓慢滴加10mL含0.54g(5mmol)2-氨甲基吡啶和0.76g(7.5mmol)三乙胺的二氯甲烷溶液,滴加完毕,室温下搅拌反应6小时。反应完毕,将反应液旋蒸浓缩,得到淡粉色固体。在冰水浴中,用去离子水充分洗涤上述淡粉色固体,过滤,烘干,得黄白色粉末1.27g,收率97%,HPLC纯度为99%。1.14g (6mmol) of p-toluenesulfonyl chloride and 10mL of dichloromethane were added to the dry reaction flask, stirred and dissolved at room temperature, and 10mL of 0.54g (5mmol) of 2-aminomethylpyridine and 0.76g (7.5mmol) of 2-aminomethylpyridine were slowly added dropwise in 10mL. The solution of triethylamine in dichloromethane was added dropwise, and the reaction was stirred at room temperature for 6 hours. After the reaction was completed, the reaction solution was concentrated by rotary evaporation to obtain a pale pink solid. In an ice-water bath, the above-mentioned pale pink solid was fully washed with deionized water, filtered and dried to obtain 1.27 g of yellow-white powder with a yield of 97% and a HPLC purity of 99%.
取一干燥的三口烧瓶,加入上述中间产品即N-(2-吡啶甲基)对甲苯磺酰胺0.66g(2.5mmol),乙二醇7.5mL,DMF-DMA7.5mL,一水合醋酸铜25mg(0.125mmol),之后升温至80℃反应8小时。反应结束,冷却至室温,加入30mL去离子水洗涤,然后用(20mL*3)乙酸乙酯萃取,合并有机层并用无水MgSO4干燥,浓缩得到黄色液体,经柱层析分离得到白色粉末0.52g,收率92%,HPLC纯度为99%。核磁数据见图1。Get a dry three-necked flask, add above-mentioned intermediate product namely N-(2-pyridylmethyl) p-toluenesulfonamide 0.66g (2.5mmol), ethylene glycol 7.5mL, DMF-DMA 7.5mL, copper acetate monohydrate 25mg ( 0.125 mmol), and then the temperature was raised to 80°C for 8 hours. The reaction was completed, cooled to room temperature, washed with 30 mL of deionized water, then extracted with (20 mL*3) ethyl acetate, the organic layers were combined and dried with anhydrous MgSO 4 , concentrated to obtain a yellow liquid, which was separated by column chromatography to obtain a white powder 0.52 g, 92% yield, 99% HPLC purity. The NMR data are shown in Figure 1.
实施例2Example 2
在干燥的反应瓶中加入1.14g(6mmol)对甲苯磺酰氯及10mL 1,2-二氯乙烷,室温下搅拌溶解,缓慢滴加10mL含0.54g(5mmol)2-氨甲基吡啶和0.76g(7.5mmol)三乙胺的1,2-二氯乙烷溶液,滴加完毕,室温下搅拌反应6小时。反应完毕,将反应液旋蒸浓缩,得到淡粉色半固体。加入40mL去离子水洗涤上述淡粉色半固体,然后用(20mL*3)乙酸乙酯萃取,合并有机层并用无水MgSO4干燥,浓缩,得黄白色固体1.16g,收率88%,HPLC纯度为99%。1.14 g (6 mmol) of p-toluenesulfonyl chloride and 10 mL of 1,2-dichloroethane were added to the dry reaction flask, stirred and dissolved at room temperature, and 10 mL of 0.54 g (5 mmol) of 2-aminomethylpyridine and 0.76 g of 2-aminomethylpyridine and 0.76 g (7.5 mmol) triethylamine solution in 1,2-dichloroethane was added dropwise, and the reaction was stirred at room temperature for 6 hours. After the reaction was completed, the reaction solution was concentrated by rotary evaporation to obtain a pale pink semi-solid. 40 mL of deionized water was added to wash the above pale pink semi-solid, then extracted with (20 mL*3) ethyl acetate, the organic layers were combined and dried over anhydrous MgSO 4 , and concentrated to obtain 1.16 g of a yellow-white solid, yield 88%, HPLC purity is 99%.
实施例3Example 3
在干燥的反应瓶中加入1.14g(6mmol)对甲苯磺酰氯及10mL四氢呋喃,室温下搅拌溶解,缓慢滴加10mL含0.54g(5mmol)2-氨甲基吡啶和0.76g(7.5mmol)三乙胺的四氢呋喃,滴加完毕,室温下搅拌反应6小时。反应完毕,将反应液旋蒸浓缩,得到淡粉色半固体。加入40mL去离子水洗涤上述淡粉色半固体,然后用(20mL*3)乙酸乙酯萃取,合并有机层并用无水MgSO4干燥,浓缩,得黄白色固体1.09g,收率83%,HPLC纯度为99%。1.14g (6mmol) of p-toluenesulfonyl chloride and 10mL of tetrahydrofuran were added to the dry reaction flask, stirred and dissolved at room temperature, and 10mL of 0.54g (5mmol) of 2-aminomethylpyridine and 0.76g (7.5mmol) of triethyl were slowly added dropwise. The amine in tetrahydrofuran was added dropwise, and the reaction was stirred at room temperature for 6 hours. After the reaction was completed, the reaction solution was concentrated by rotary evaporation to obtain a pale pink semi-solid. 40 mL of deionized water was added to wash the above pale pink semi-solid, then extracted with (20 mL*3) ethyl acetate, the organic layers were combined and dried over anhydrous MgSO 4 , and concentrated to obtain 1.09 g of a yellow-white solid, yield 83%, HPLC purity is 99%.
实施例4Example 4
在干燥的反应瓶中加入1.14g(6mmol)对甲苯磺酰氯及10mL二氯甲烷,室温下搅拌溶解,缓慢滴加10mL含0.54g(5mmol)2-氨甲基吡啶和0.44g(7.5mmol)三甲胺的二氯甲烷溶液,滴加完毕,室温下搅拌反应6小时。反应完毕,将反应液旋蒸浓缩,得到淡粉色固体。在冰水浴中,用去离子水充分洗涤上述淡粉色固体,过滤,烘干,得黄白色粉末1.18g,收率90%,HPLC纯度为99%。1.14g (6mmol) of p-toluenesulfonyl chloride and 10mL of dichloromethane were added to the dry reaction flask, stirred and dissolved at room temperature, and 10mL of 0.54g (5mmol) of 2-aminomethylpyridine and 0.44g (7.5mmol) of 0.54g (5mmol) of 2-aminomethylpyridine and 0.44g (7.5mmol) were slowly added dropwise The solution of trimethylamine in dichloromethane was added dropwise, and the reaction was stirred at room temperature for 6 hours. After the reaction was completed, the reaction solution was concentrated by rotary evaporation to obtain a pale pink solid. In an ice-water bath, the above pale pink solid was fully washed with deionized water, filtered and dried to obtain 1.18 g of a yellow-white powder with a yield of 90% and a HPLC purity of 99%.
实施例5Example 5
在干燥的反应瓶中加入1.14g(6mmol)对甲苯磺酰氯及10mL二氯甲烷,室温下搅拌溶解,缓慢滴加10mL含0.54g(5mmol)2-氨甲基吡啶和0.59g(7.5mmol)吡啶的二氯甲烷溶液,滴加完毕,室温下搅拌反应6小时。反应完毕,将反应液旋蒸浓缩,得到淡粉色固体。在冰水浴中,用去离子水充分洗涤上述淡粉色固体,过滤,烘干,得黄白色粉末1.13g,收率86%,HPLC纯度为99%。1.14g (6mmol) of p-toluenesulfonyl chloride and 10mL of dichloromethane were added to the dry reaction flask, stirred and dissolved at room temperature, and 10mL of 0.54g (5mmol) of 2-aminomethylpyridine and 0.59g (7.5mmol) of 0.54g (5mmol) of 2-aminomethylpyridine and 0.59g (7.5mmol) were slowly added dropwise. The solution of pyridine in dichloromethane was added dropwise, and the reaction was stirred at room temperature for 6 hours. After the reaction was completed, the reaction solution was concentrated by rotary evaporation to obtain a pale pink solid. In an ice-water bath, the above pale pink solid was fully washed with deionized water, filtered and dried to obtain 1.13 g of a yellow-white powder with a yield of 86% and a HPLC purity of 99%.
实施例6Example 6
在干燥的反应瓶中加入1.14g(6mmol)对甲苯磺酰氯及10mL二氯甲烷,室温下搅拌溶解,缓慢滴加10mL含0.54g(5mmol)2-氨甲基吡啶和0.63g(7.5mmol)哌啶的二氯甲烷溶液,滴加完毕,室温下搅拌反应6小时。反应完毕,将反应液旋蒸浓缩,得到淡粉色固体。在冰水浴中,用去离子水充分洗涤上述淡粉色固体,过滤,烘干,得黄白色粉末1.19g,收率91%,HPLC纯度为99%。1.14g (6mmol) of p-toluenesulfonyl chloride and 10mL of dichloromethane were added to the dry reaction flask, stirred and dissolved at room temperature, and 10mL containing 0.54g (5mmol) of 2-aminomethylpyridine and 0.63g (7.5mmol) of 0.54g (5mmol) was slowly added dropwise. The solution of piperidine in dichloromethane was added dropwise, and the reaction was stirred at room temperature for 6 hours. After the reaction was completed, the reaction solution was concentrated by rotary evaporation to obtain a pale pink solid. In an ice-water bath, the above pale pink solid was fully washed with deionized water, filtered and dried to obtain 1.19 g of a yellow-white powder with a yield of 91% and a HPLC purity of 99%.
实施例7Example 7
取一干燥的三口烧瓶,加入按照实施例1的方法制备得到的中间产品即N-(2-吡啶甲基)对甲苯磺酰胺0.65g(2.5mmol),异丙醇7.5mL,DMF-DMA 7.5mL,一水合醋酸铜25mg(0.125mmol),之后升温至80℃反应8小时。反应结束,冷却至室温,加入30mL去离子水洗涤,然后用(20mL*3)乙酸乙酯萃取,合并有机层并用无水MgSO4干燥,浓缩得到黄色液体,经柱层析分离得到白色粉末0.24g,收率42%,HPLC纯度为99%。Take a dry three-necked flask, add the intermediate product prepared according to the method of Example 1, namely N-(2-pyridylmethyl) p-toluenesulfonamide 0.65g (2.5mmol), isopropanol 7.5mL, DMF-DMA 7.5g mL, 25 mg (0.125 mmol) of copper acetate monohydrate, and then the temperature was raised to 80° C. to react for 8 hours. The reaction was completed, cooled to room temperature, washed with 30 mL of deionized water, then extracted with (20 mL*3) ethyl acetate, the organic layers were combined and dried with anhydrous MgSO 4 , concentrated to obtain a yellow liquid, which was separated by column chromatography to obtain a white powder 0.24 g, yield 42%, HPLC purity 99%.
实施例8Example 8
取一干燥的三口烧瓶,加入按照实施例1的方法制备得到的中间产品即N-(2-吡啶甲基)对甲苯磺酰胺0.65g(2.5mmol),正丙醇7.5mL,DMF-DMA 7.5mL,一水合醋酸铜25mg(0.125mmol),之后升温至80℃反应8小时。反应结束,冷却至室温,加入30mL去离子水洗涤,然后用(20mL*3)乙酸乙酯萃取,合并有机层并用无水MgSO4干燥,浓缩得到黄色液体,经柱层析分离得到白色粉末0.32g,收率57%,HPLC纯度为99%。Take a dry three-necked flask, add the intermediate product prepared according to the method in Example 1, namely N-(2-pyridylmethyl) p-toluenesulfonamide 0.65g (2.5mmol), n-propanol 7.5mL, DMF-DMA 7.5g mL, 25 mg (0.125 mmol) of copper acetate monohydrate, and then the temperature was raised to 80° C. to react for 8 hours. The reaction was completed, cooled to room temperature, washed with 30 mL of deionized water, then extracted with (20 mL*3) ethyl acetate, the organic layers were combined and dried with anhydrous MgSO 4 , concentrated to obtain a yellow liquid, which was separated by column chromatography to obtain a white powder 0.32 g, yield 57%, HPLC purity 99%.
实施例9Example 9
取一干燥的三口烧瓶,加入按照实施例1的方法制备得到的中间产品即N-(2-吡啶甲基)对甲苯磺酰胺0.65g(2.5mmol),正丁醇7.5mL,DMF-DMA 7.5mL,一水合醋酸铜25mg(0.125mmol),之后升温至80℃反应8小时。反应结束,冷却至室温,加入30mL去离子水洗涤,然后用(20mL*3)乙酸乙酯萃取,合并有机层并用无水MgSO4干燥,浓缩得到黄色液体,经柱层析分离得到白色粉末0.29g,收率51%,HPLC纯度为99%。Take a dry three-necked flask, add the intermediate product prepared according to the method of Example 1, namely N-(2-pyridylmethyl) p-toluenesulfonamide 0.65g (2.5mmol), n-butanol 7.5mL, DMF-DMA 7.5 mL, 25 mg (0.125 mmol) of copper acetate monohydrate, and then the temperature was raised to 80° C. to react for 8 hours. The reaction was completed, cooled to room temperature, washed with 30 mL of deionized water, then extracted with (20 mL*3) ethyl acetate, the organic layers were combined and dried over anhydrous MgSO 4 , concentrated to obtain a yellow liquid, which was separated by column chromatography to obtain a white powder 0.29 g, yield 51%, HPLC purity 99%.
实施例10Example 10
取一干燥的三口烧瓶,加入按照实施例1的方法制备得到的中间产品即N-(2-吡啶甲基)对甲苯磺酰胺0.65g(2.5mmol),二乙二醇7.5mL,DMF-DMA 7.5mL,一水合醋酸铜25mg(0.125mmol),之后升温至80℃反应8小时。反应结束,冷却至室温,加入30mL去离子水洗涤,然后用(20mL*3)乙酸乙酯萃取,合并有机层并用无水MgSO4干燥,浓缩得到黄色液体,经柱层析分离得到白色粉末0.41g,收率73%,HPLC纯度为99%。Take a dry three-necked flask, add the intermediate product prepared according to the method of Example 1, namely N-(2-pyridylmethyl) p-toluenesulfonamide 0.65g (2.5mmol), diethylene glycol 7.5mL, DMF-DMA 7.5 mL, 25 mg (0.125 mmol) of copper acetate monohydrate, and then the temperature was raised to 80° C. to react for 8 hours. The reaction was completed, cooled to room temperature, washed with 30 mL of deionized water, then extracted with (20 mL*3) ethyl acetate, the organic layers were combined and dried with anhydrous MgSO 4 , concentrated to obtain a yellow liquid, which was separated by column chromatography to obtain a white powder 0.41 g, 73% yield, 99% HPLC purity.
实施例11Example 11
取一干燥的三口烧瓶,加入按照实施例1的方法制备得到的中间产品即N-(2-吡啶甲基)对甲苯磺酰胺0.65g(2.5mmol),乙二醇7.5mL,DMF-DMA 7.5mL,氯化亚铜12mg(0.125mmol),之后升温至80℃反应8小时。反应结束,冷却至室温,加入30mL去离子水洗涤,然后用(20mL*3)乙酸乙酯萃取,合并有机层并用无水MgSO4干燥,浓缩得到黄色液体,经柱层析分离得到白色粉末0.47g,收率84%,HPLC纯度为99%。Take a dry three-necked flask, add the intermediate product prepared according to the method of Example 1, namely N-(2-pyridylmethyl) p-toluenesulfonamide 0.65g (2.5mmol), ethylene glycol 7.5mL, DMF-DMA 7.5 mL, 12 mg (0.125 mmol) of cuprous chloride, and then the temperature was raised to 80° C. to react for 8 hours. The reaction was completed, cooled to room temperature, washed with 30 mL of deionized water, then extracted with (20 mL*3) ethyl acetate, the organic layers were combined and dried with anhydrous MgSO 4 , concentrated to obtain a yellow liquid, which was separated by column chromatography to obtain a white powder 0.47 g g, 84% yield, 99% HPLC purity.
实施例12Example 12
取一干燥的三口烧瓶,加入按照实施例1的方法制备得到的中间产品即N-(2-吡啶甲基)对甲苯磺酰胺0.65g(2.5mmol),乙二醇7.5mL,DMF-DMA 7.5mL,氯化铜19mg(0.125mmol),之后升温至80℃反应8小时。反应结束,冷却至室温,加入30mL去离子水洗涤,然后用(20mL*3)乙酸乙酯萃取,合并有机层并用无水MgSO4干燥,浓缩得到黄色液体,经柱层析分离得到白色粉末0.43g,收率77%,HPLC纯度为99%。Take a dry three-necked flask, add the intermediate product prepared according to the method of Example 1, namely N-(2-pyridylmethyl) p-toluenesulfonamide 0.65g (2.5mmol), ethylene glycol 7.5mL, DMF-DMA 7.5 mL, 19 mg (0.125 mmol) of copper chloride, and then the temperature was raised to 80° C. to react for 8 hours. The reaction was completed, cooled to room temperature, washed with 30 mL of deionized water, then extracted with (20 mL*3) ethyl acetate, the organic layers were combined and dried with anhydrous MgSO 4 , concentrated to obtain a yellow liquid, which was separated by column chromatography to obtain a white powder 0.43 g, 77% yield, 99% HPLC purity.
实施例13Example 13
取一干燥的三口烧瓶,加入按照实施例1的方法制备得到的中间产品即N-(2-吡啶甲基)对甲苯磺酰胺0.65g(2.5mmol),乙二醇7.5mL,DMF-DMA 7.5mL,硝酸铜23mg(0.125mmol),之后升温至80℃反应8小时。反应结束,冷却至室温,加入30mL去离子水洗涤,然后用(20mL*3)乙酸乙酯萃取,合并有机层并用无水MgSO4干燥,浓缩得到黄色液体,经柱层析分离得到白色粉末0.46g,收率82%,HPLC纯度为99%。Take a dry three-necked flask, add the intermediate product prepared according to the method of Example 1, namely N-(2-pyridylmethyl) p-toluenesulfonamide 0.65g (2.5mmol), ethylene glycol 7.5mL, DMF-DMA 7.5 mL, 23 mg (0.125 mmol) of copper nitrate, and then the temperature was raised to 80° C. to react for 8 hours. The reaction was completed, cooled to room temperature, washed with 30 mL of deionized water, then extracted with (20 mL*3) ethyl acetate, the organic layers were combined and dried with anhydrous MgSO 4 , concentrated to obtain a yellow liquid, which was separated by column chromatography to obtain a white powder 0.46 g, 82% yield, 99% HPLC purity.
实施例14Example 14
取一干燥的三口烧瓶,加入按照实施例1的方法制备得到的中间产品即N-(2-吡啶甲基)对甲苯磺酰胺0.65g(2.5mmol),乙二醇7.5mL,DMF-DMA 7.5mL,溴化铜28mg(0.125mmol),之后升温至80℃反应8小时。反应结束,冷却至室温,加入30mL去离子水洗涤,然后用(20mL*3)乙酸乙酯萃取,合并有机层并用无水MgSO4干燥,浓缩得到黄色液体,经柱层析分离得到白色粉末0.40g,收率71%,HPLC纯度为99%。Take a dry three-necked flask, add the intermediate product prepared according to the method of Example 1, namely N-(2-pyridylmethyl) p-toluenesulfonamide 0.65g (2.5mmol), ethylene glycol 7.5mL, DMF-DMA 7.5 mL, 28 mg (0.125 mmol) of copper bromide, and then the temperature was raised to 80° C. to react for 8 hours. The reaction was completed, cooled to room temperature, washed with 30 mL of deionized water, then extracted with (20 mL*3) ethyl acetate, the organic layers were combined and dried with anhydrous MgSO 4 , concentrated to obtain a yellow liquid, which was separated by column chromatography to obtain a white powder 0.40 g, 71% yield, 99% HPLC purity.
实施例15Example 15
取一干燥的三口烧瓶,加入按照实施例1的方法制备得到的中间产品即N-(2-吡啶甲基)对甲苯磺酰胺0.65g(2.5mmol),乙二醇7.5mL,DMF-DMA 7.5mL,溴化亚铜18mg(0.125mmol),之后升温至80℃反应8小时。反应结束,冷却至室温,加入30mL去离子水洗涤,然后用(20mL*3)乙酸乙酯萃取,合并有机层并用无水MgSO4干燥,浓缩得到黄色液体,经柱层析分离得到白色粉末0.41g,收率73%,HPLC纯度为99%。Take a dry three-necked flask, add the intermediate product prepared according to the method of Example 1, namely N-(2-pyridylmethyl) p-toluenesulfonamide 0.65g (2.5mmol), ethylene glycol 7.5mL, DMF-DMA 7.5 mL, 18 mg (0.125 mmol) of cuprous bromide, and then the temperature was raised to 80° C. to react for 8 hours. The reaction was completed, cooled to room temperature, washed with 30 mL of deionized water, then extracted with (20 mL*3) ethyl acetate, the organic layers were combined and dried with anhydrous MgSO 4 , concentrated to obtain a yellow liquid, which was separated by column chromatography to obtain a white powder 0.41 g, 73% yield, 99% HPLC purity.
实施例16Example 16
在干燥的反应瓶中加入1.40g(6mmol)对叔丁基苯磺酰氯及10mL二氯甲烷,室温下搅拌溶解,缓慢滴加10mL含0.54g(5mmol)2-氨甲基吡啶和0.76g(7.5mmol)三乙胺的二氯甲烷溶液,滴加完毕,室温下搅拌反应6小时。反应完毕,将反应液旋蒸浓缩,得到糊状物。在冰水浴中,用去离子水充分洗涤上述糊状物,其凝固成固体,过滤,烘干,得白色粉末1.43g,收率94%,HPLC纯度为99%。1.40g (6mmol) of p-tert-butylbenzenesulfonyl chloride and 10mL of dichloromethane were added to the dry reaction flask, stirred and dissolved at room temperature, and 10mL of 0.54g (5mmol) of 2-aminomethylpyridine and 0.76g ( 7.5 mmol) triethylamine solution in dichloromethane was added dropwise, and the reaction was stirred at room temperature for 6 hours. After the completion of the reaction, the reaction solution was concentrated by rotary evaporation to obtain a paste. In an ice-water bath, the above paste was fully washed with deionized water, solidified into a solid, filtered and dried to obtain 1.43 g of white powder with a yield of 94% and a HPLC purity of 99%.
取一干燥的三口烧瓶,加入上述中间产品即N-(2-吡啶甲基)对叔丁基苯磺酰胺0.76g(2.5mmol),乙二醇7.5mL,DMF-DMA 7.5mL,一水合醋酸铜25mg(0.125mmol),之后升温至80℃反应8小时。反应结束,冷却至室温,加入30mL去离子水洗涤,然后用(20mL*3)乙酸乙酯萃取,合并有机层并用无水MgSO4干燥,浓缩得到黄色液体,经柱层析分离得到白色粉末0.60g,收率89%,HPLC纯度为99%。核磁数据见图2。Get a dry three-necked flask, add above-mentioned intermediate product namely N-(2-pyridylmethyl) p-tert-butylbenzenesulfonamide 0.76g (2.5mmol), ethylene glycol 7.5mL, DMF-DMA 7.5mL, acetic acid monohydrate After 25 mg (0.125 mmol) of copper, the temperature was raised to 80° C. and reacted for 8 hours. The reaction was completed, cooled to room temperature, washed with 30 mL of deionized water, then extracted with (20 mL*3) ethyl acetate, the organic layers were combined and dried with anhydrous MgSO 4 , concentrated to obtain a yellow liquid, which was separated by column chromatography to obtain a white powder 0.60 g, yield 89%, HPLC purity 99%. The NMR data are shown in Figure 2.
实施例17Example 17
在干燥的反应瓶中加入1.24g(6mmol)对甲氧基苯磺酰氯及10mL二氯甲烷,室温下搅拌溶解,缓慢滴加10mL含0.54g(5mmol)2-氨甲基吡啶和0.76g(7.5mmol)三乙胺的二氯甲烷溶液,滴加完毕,室温下搅拌反应6小时。反应完毕,将反应液旋蒸浓缩,得到糊状物。在冰水浴中,用去离子水充分洗涤上述糊状物,其凝固成固体,过滤,烘干,得黄白色粉末1.26g,收率91%,HPLC纯度为99%。1.24g (6mmol) of p-methoxybenzenesulfonyl chloride and 10mL of dichloromethane were added to the dry reaction flask, stirred and dissolved at room temperature, and 10mL of 0.54g (5mmol) of 2-aminomethylpyridine and 0.76g ( 7.5 mmol) triethylamine solution in dichloromethane was added dropwise, and the reaction was stirred at room temperature for 6 hours. After the completion of the reaction, the reaction solution was concentrated by rotary evaporation to obtain a paste. In an ice-water bath, the paste was fully washed with deionized water, solidified into a solid, filtered and dried to obtain 1.26 g of a yellow-white powder with a yield of 91% and a HPLC purity of 99%.
取一干燥的三口烧瓶,加入上述中间产品即N-(2-吡啶甲基)对甲氧基苯磺酰胺0.70g(2.5mmol),乙二醇7.5mL,DMF-DMA7.5mL,一水合醋酸铜25mg(0.125mmol),之后升温至80℃反应8小时。反应结束,冷却至室温,加入30mL去离子水洗涤,然后用(20mL*3)乙酸乙酯萃取,合并有机层并用无水MgSO4干燥,浓缩得到黄色液体,经柱层析分离得到白色粉末0.52g,收率86%,HPLC纯度为99%。核磁数据见图3。Take a dry three-necked flask, add the above-mentioned intermediate product, namely N-(2-pyridylmethyl) p-methoxybenzenesulfonamide 0.70g (2.5mmol), ethylene glycol 7.5mL, DMF-DMA 7.5mL, acetic acid monohydrate After 25 mg (0.125 mmol) of copper, the temperature was raised to 80° C. and reacted for 8 hours. The reaction was completed, cooled to room temperature, washed with 30 mL of deionized water, then extracted with (20 mL*3) ethyl acetate, the organic layers were combined and dried with anhydrous MgSO 4 , concentrated to obtain a yellow liquid, which was separated by column chromatography to obtain a white powder 0.52 g, yield 86%, HPLC purity 99%. The NMR data are shown in Figure 3.
实施例18Example 18
在干燥的反应瓶中加入1.06g(6mmol)苯磺酰氯及10mL二氯甲烷,室温下搅拌溶解,缓慢滴加10mL含0.54g(5mmol)2-氨甲基吡啶和0.76g(7.5mmol)三乙胺的二氯甲烷溶液,滴加完毕,室温下搅拌反应6小时。反应完毕,将反应液旋蒸浓缩,得到糊状物。在冰水浴中,用去离子水充分洗涤上述糊状物,其凝固成固体,过滤,烘干,得白色粉末1.05g,收率85%,,HPLC纯度为99%。Add 1.06g (6mmol) of benzenesulfonyl chloride and 10mL of dichloromethane to the dry reaction flask, stir and dissolve at room temperature, and slowly dropwise add 10mL containing 0.54g (5mmol) of 2-aminomethylpyridine and 0.76g (7.5mmol) of trichloromethane. The dichloromethane solution of ethylamine was added dropwise, and the reaction was stirred at room temperature for 6 hours. After the completion of the reaction, the reaction solution was concentrated by rotary evaporation to obtain a paste. In an ice-water bath, the above paste was fully washed with deionized water, solidified into a solid, filtered and dried to obtain 1.05 g of white powder with a yield of 85% and HPLC purity of 99%.
取一干燥的三口烧瓶,加入上述中间产品即N-(2-吡啶甲基)苯磺酰胺0.62g(2.5mmol),乙二醇7.5mL,DMF-DMA 7.5mL,一水合醋酸铜25mg(0.125mmol),之后升温至80℃反应8小时。反应结束,冷却至室温,加入30mL去离子水洗涤,然后用(20mL*3)乙酸乙酯萃取,合并有机层并用无水MgSO4干燥,浓缩得到黄色液体,经柱层析分离得到白色粉末0.36g,收率67%,HPLC纯度为99%。核磁数据见图4。Get a dry three-necked flask, add above-mentioned intermediate product namely N-(2-pyridylmethyl) benzenesulfonamide 0.62g (2.5mmol), ethylene glycol 7.5mL, DMF-DMA 7.5mL, copper acetate monohydrate 25mg (0.125g) mmol), and then the temperature was raised to 80°C for 8 hours. The reaction was completed, cooled to room temperature, washed with 30 mL of deionized water, then extracted with (20 mL*3) ethyl acetate, the organic layers were combined and dried with anhydrous MgSO 4 , concentrated to obtain a yellow liquid, which was separated by column chromatography to obtain a white powder 0.36 g, yield 67%, HPLC purity 99%. The NMR data are shown in Figure 4.
实施例19Example 19
在干燥的反应瓶中加入1.53g(6mmol)对溴基苯磺酰氯及10mL二氯甲烷,室温下搅拌溶解,缓慢滴加10mL含0.54g(5mmol)2-氨甲基吡啶和0.76g(7.5mmol)三乙胺的二氯甲烷溶液,滴加完毕,室温下搅拌反应6小时。反应完毕,将反应液旋蒸浓缩,得到糊状物。在冰水浴中,用去离子水充分洗涤上述糊状物,其凝固成固体,过滤,烘干,得白色粉末1.47g,收率90%,HPLC纯度为99%。1.53g (6mmol) of p-bromobenzenesulfonyl chloride and 10mL of dichloromethane were added to the dry reaction flask, stirred and dissolved at room temperature, and 10mL of 0.54g (5mmol) of 2-aminomethylpyridine and 0.76g (7.5g of 2-aminomethylpyridine) were slowly added dropwise. mmol) triethylamine in dichloromethane, the dropwise addition was completed, and the reaction was stirred at room temperature for 6 hours. After the reaction was completed, the reaction solution was concentrated by rotary evaporation to obtain a paste. In an ice-water bath, the above paste was fully washed with deionized water, solidified into a solid, filtered and dried to obtain 1.47 g of white powder with a yield of 90% and a HPLC purity of 99%.
取一干燥的三口烧瓶,加入上述中间产品即N-(2-吡啶甲基)对溴基苯磺酰胺0.82g(2.5mmol),乙二醇7.5mL,DMF-DMA7.5mL,一水合醋酸铜25mg(0.125mmol),之后升温至80℃反应8小时。反应结束,冷却至室温,加入30mL去离子水洗涤,然后用(20mL*3)乙酸乙酯萃取,合并有机层并用无水MgSO4干燥,浓缩得到黄色液体,经柱层析分离得到白色粉末0.68g,收率93%,HPLC纯度为99%。核磁数据见图5。Take a dry three-necked flask, add the above-mentioned intermediate product, namely N-(2-pyridylmethyl) p-bromobenzenesulfonamide 0.82g (2.5mmol), ethylene glycol 7.5mL, DMF-DMA 7.5mL, copper acetate monohydrate 25 mg (0.125 mmol), and then the temperature was raised to 80° C. to react for 8 hours. The reaction was completed, cooled to room temperature, washed with 30 mL of deionized water, then extracted with (20 mL*3) ethyl acetate, the organic layers were combined and dried with anhydrous MgSO 4 , concentrated to obtain a yellow liquid, which was separated by column chromatography to obtain a white powder 0.68 g, 93% yield, 99% HPLC purity. The NMR data are shown in Figure 5.
实施例20Example 20
在干燥的反应瓶中加入1.31g(6mmol)均三甲基苯磺酰氯及10mL二氯甲烷,室温下搅拌溶解,缓慢滴加10mL含0.54g(5mmol)2-氨甲基吡啶和0.76g(7.5mmol)三乙胺的二氯甲烷溶液,滴加完毕,室温下搅拌反应6小时。反应完毕,将反应液旋蒸浓缩,得到糊状物。在冰水浴中,用去离子水充分洗涤上述糊状物,其凝固成固体,过滤,烘干,得黄白色粉末1.35g,收率93%,HPLC纯度为99%。1.31 g (6 mmol) of mesitylene sulfonyl chloride and 10 mL of dichloromethane were added to the dry reaction flask, stirred and dissolved at room temperature, and 10 mL of 0.54 g (5 mmol) of 2-aminomethylpyridine and 0.76 g ( 7.5 mmol) triethylamine solution in dichloromethane was added dropwise, and the reaction was stirred at room temperature for 6 hours. After the completion of the reaction, the reaction solution was concentrated by rotary evaporation to obtain a paste. In an ice-water bath, the paste was fully washed with deionized water, solidified into a solid, filtered and dried to obtain 1.35 g of a yellow-white powder with a yield of 93% and HPLC purity of 99%.
取一干燥的三口烧瓶,加入上述中间产品即N-(2-吡啶甲基)均三甲基苯磺酰胺0.73g(2.5mmol),乙二醇7.5mL,DMF-DMA 7.5mL,一水合醋酸铜25mg(0.125mmol),之后升温至80℃反应8小时。反应结束,冷却至室温,加入30mL去离子水洗涤,然后用(20mL*3)乙酸乙酯萃取,合并有机层并用无水MgSO4干燥,浓缩得到棕黄色液体,经柱层析分离得到白色粉末0.60g,收率94%,HPLC纯度为99%。核磁数据见图6、图7。Get a dry three-necked flask, add above-mentioned intermediate product namely N-(2-pyridylmethyl) mesitylene sulfonamide 0.73g (2.5mmol), ethylene glycol 7.5mL, DMF-DMA 7.5mL, acetic acid monohydrate After 25 mg (0.125 mmol) of copper, the temperature was raised to 80° C. and reacted for 8 hours. The reaction was completed, cooled to room temperature, washed with 30 mL of deionized water, and then extracted with (20 mL*3) ethyl acetate. The organic layers were combined and dried with anhydrous MgSO 4 . Concentrated to obtain a brownish-yellow liquid, which was separated by column chromatography to obtain a white powder 0.60 g, yield 94%, HPLC purity 99%. The NMR data are shown in Figure 6 and Figure 7.
实施例1、7~15所得目标产品经核磁数据、熔点数据检测,与已报道文献中对甲苯磺酰脒基本一致。The target products obtained in Examples 1 and 7-15 are basically consistent with the p-toluenesulfonyl amidine in the reported literature through the detection of nuclear magnetic data and melting point data.
熔点:134.6℃-135.0℃。Melting point: 134.6℃-135.0℃.
实施例16所得目标产品经核磁数据、熔点数据检测,与已报道文献中对叔丁基苯磺酰脒基本一致。The target product obtained in Example 16 is basically consistent with the p-tert-butylbenzenesulfonyl amidine in the reported literature through the detection of nuclear magnetic data and melting point data.
熔点:161.2℃-162.1℃。Melting point: 161.2℃-162.1℃.
实施例17所得目标产品经核磁数据、熔点数据检测,与已报道文献中对甲氧基苯磺酰脒基本一致。The target product obtained in Example 17 is basically consistent with the p-methoxybenzenesulfonyl amidine in the reported literature through the detection of nuclear magnetic data and melting point data.
熔点:152.2℃-153.7℃。Melting point: 152.2℃-153.7℃.
实施例18所得目标产品经核磁数据、熔点数据检测,与已报道文献中苯磺酰脒基本一致。The target product obtained in Example 18 was detected by nuclear magnetic data and melting point data, which was basically consistent with the benzenesulfonyl amidine in the reported literature.
熔点:129.1℃-131.1℃。Melting point: 129.1℃-131.1℃.
实施例19所得目标产品经核磁数据、熔点数据检测,与已报道文献中对溴基苯磺酰脒基本一致。The target product obtained in Example 19 was detected by nuclear magnetic data and melting point data, which was basically consistent with the p-bromobenzenesulfonyl amidine in the reported literature.
熔点:142.5℃-143.0℃。Melting point: 142.5℃-143.0℃.
实施例20所得目标产品经核磁数据、熔点数据检测可判定为均三甲基苯磺酰脒。The target product obtained in Example 20 can be determined to be mesitylenesulfonyl amidine through the detection of nuclear magnetic data and melting point data.
熔点:159.4℃-159.9℃。Melting point: 159.4℃-159.9℃.
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010510716.1A CN111574413B (en) | 2020-06-08 | 2020-06-08 | A kind of preparation method of sulfonyl amidine with 2-aminomethylpyridine and DMF-DMA as amine source |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010510716.1A CN111574413B (en) | 2020-06-08 | 2020-06-08 | A kind of preparation method of sulfonyl amidine with 2-aminomethylpyridine and DMF-DMA as amine source |
Publications (2)
Publication Number | Publication Date |
---|---|
CN111574413A true CN111574413A (en) | 2020-08-25 |
CN111574413B CN111574413B (en) | 2022-04-05 |
Family
ID=72127359
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010510716.1A Active CN111574413B (en) | 2020-06-08 | 2020-06-08 | A kind of preparation method of sulfonyl amidine with 2-aminomethylpyridine and DMF-DMA as amine source |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111574413B (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114940657A (en) * | 2022-05-09 | 2022-08-26 | 三峡大学 | Amidine compound synthesized from N, N, N ', N' -tetramethylethylenediamine |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101039919A (en) * | 2004-10-13 | 2007-09-19 | 惠氏公司 | N-benzenesulfonyl substituted anilino-pyrimidine analogs |
CN101213187A (en) * | 2005-06-28 | 2008-07-02 | 塞诺菲-安万特股份有限公司 | Isoquinoline derivatives as inhibitors of RHO-kinase |
CN101611012A (en) * | 2006-12-27 | 2009-12-23 | 塞诺菲-安万特股份有限公司 | The isoquinilone derivatives that Cycloalkyl amine replaces |
CN104016904A (en) * | 2014-06-04 | 2014-09-03 | 常州大学 | Multi-substituted amidine compound as well as preparation method and application thereof |
WO2018085170A1 (en) * | 2016-11-01 | 2018-05-11 | Merck Sharp & Dohme Corp. | Substituted 6-membered aryl or heteroaryl allosteric modulators of nicotinic acetylcholine receptors |
WO2018109649A1 (en) * | 2016-12-15 | 2018-06-21 | Glaxosmithkline Intellectual Property Development Limited | Ether linked triazoles as nrf2 regulators |
CN109516987A (en) * | 2018-12-26 | 2019-03-26 | 江西富祥药业股份有限公司 | A kind of AVM hereinafter Batan centre preparation |
-
2020
- 2020-06-08 CN CN202010510716.1A patent/CN111574413B/en active Active
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101039919A (en) * | 2004-10-13 | 2007-09-19 | 惠氏公司 | N-benzenesulfonyl substituted anilino-pyrimidine analogs |
CN101213187A (en) * | 2005-06-28 | 2008-07-02 | 塞诺菲-安万特股份有限公司 | Isoquinoline derivatives as inhibitors of RHO-kinase |
CN101611012A (en) * | 2006-12-27 | 2009-12-23 | 塞诺菲-安万特股份有限公司 | The isoquinilone derivatives that Cycloalkyl amine replaces |
CN104016904A (en) * | 2014-06-04 | 2014-09-03 | 常州大学 | Multi-substituted amidine compound as well as preparation method and application thereof |
WO2018085170A1 (en) * | 2016-11-01 | 2018-05-11 | Merck Sharp & Dohme Corp. | Substituted 6-membered aryl or heteroaryl allosteric modulators of nicotinic acetylcholine receptors |
WO2018109649A1 (en) * | 2016-12-15 | 2018-06-21 | Glaxosmithkline Intellectual Property Development Limited | Ether linked triazoles as nrf2 regulators |
CN109516987A (en) * | 2018-12-26 | 2019-03-26 | 江西富祥药业股份有限公司 | A kind of AVM hereinafter Batan centre preparation |
Non-Patent Citations (8)
Title |
---|
BI, WEN-ZHU ET AL: "Air-Induced One-Pot Synthesis of N-Sulfonylformamidines from Sulfonyl Chlorides, NaN3,and Tertiary/Secondary Amines", 《EUROPEAN JOURNAL OF ORGANIC CHEMISTRY》 * |
HUANG, ZHI-YOU ET AL: "An efficient one-pot access to N-(pyridin-2-ylmethyl) substituent biphenyl-4-sulfonamides through water-promoted, palladium-catalyzed,microwave-assisted reactions", 《RSC ADVANCES》 * |
JEONG, YURI ET AL: "A Novel Synthesis of N-Sulfonylformamidines from N-Sulfonylsulfonamides", 《SYNTHESIS》 * |
KHODAIRY, A. ET AL: "4-Toluenesulfonamide as a Building Block for Synthesis of Novel Triazepines, Pyrimidines, and Azoles", 《JOURNAL OF HETEROCYCLIC CHEMISTRY》 * |
LUECKING, ULRICH ET AL: "Macrocyclic aminopyrimidines as multitarget CDK and VEGF-R inhibitors with potent antiproliferative activities", 《CHEMMEDCHEM》 * |
伍悦瑄等: "N-氨基磺酰基甲脒类化合物的合成研究", 《化学试剂》 * |
张娟等: "酰胺缩醛法合成N,N,N"-三取代甲脒的研究", 《化学通报》 * |
张磊等: "N-氨基酰基甲脒类化合物的合成研究", 《化学与生物工程》 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114940657A (en) * | 2022-05-09 | 2022-08-26 | 三峡大学 | Amidine compound synthesized from N, N, N ', N' -tetramethylethylenediamine |
CN114940657B (en) * | 2022-05-09 | 2023-10-27 | 三峡大学 | Amidine compound synthesized from N, N, N ', N' -tetramethyl ethylenediamine |
Also Published As
Publication number | Publication date |
---|---|
CN111574413B (en) | 2022-04-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN114409515B (en) | A kind of preparation method of gem-difluoroalkene compound | |
CN111925356B (en) | Synthesis method and application of chiral quinoline-imidazoline ligand | |
CN111039737B (en) | A kind of synthetic method of 2-cyanoalkylsulfonyl 3,4-dihydronaphthalene compound | |
CN108314658A (en) | A kind of preparation method of Duo substituted oxazoles derivative | |
CN108947877A (en) | A kind of chiral beta-hydroxy sulfone and preparation method thereof | |
CN108148069A (en) | A kind of synthetic method of furanone and pyridine compounds | |
CN111574413A (en) | A kind of preparation method of sulfonyl amidine with 2-aminomethylpyridine and DMF-DMA as amine source | |
CN111763222A (en) | Intermediate for preparing edoxaban free base and preparation method and application thereof | |
CN108003086A (en) | A kind of preparation method of 3- amidos -2- indole ketone compounds | |
CN110256493A (en) | A kind of C2- phosphono benzazolyl compounds and preparation method thereof | |
CN105218540A (en) | The preparation method of a kind of C-3 position thiocarbamoyl imidazole also [1,2-a] pyridine compounds and their | |
CN110105274B (en) | Synthetic method of 3- (2-amino aryl) quinoline compound | |
CN111620896A (en) | Preparation method of tetra-coordinated N, N-chelated diaryl borate compound with 8-aminoquinoline derivative as bidentate ligand | |
CN102558095A (en) | Method for preparing aromatic amine compound | |
CN103012502B (en) | Heteronuclear iridium gold bicyclo metal compound as well as preparation method and application of compound | |
CN110790689A (en) | A kind of synthetic method of 1,1-difluoro-2-isonitrile-ethylphenyl sulfone compounds | |
CN110041220A (en) | A kind of symmetrical imide analog compounds and its synthetic method | |
CN106966948B (en) | A kind of synthetic method of gem-difluoro substituted pyrrolidone compound | |
CN110038632B (en) | Preparation of a sulfonic acid functionalized lignin heterogeneous catalyst and a method for synthesizing amide compounds using the catalyst | |
CN113754604B (en) | Nitrogen-containing chiral ligand and application thereof in asymmetric oxidation reaction of thioether | |
CN108503501A (en) | A method of synthesis 2- fluoro-N- substituted aryl Carbox amides | |
CN114853555A (en) | Synthesis process of asymmetric disulfide compound | |
CN107778182A (en) | Method for synthesizing N-alkyl arylamine | |
CN109438299B (en) | Method for synthesizing benzenesulfonyl enamine compound from benzenesulfonyl hydrazide derivative and triethylamine under metal-free catalysis | |
CN110078661B (en) | A kind of preparation method of 3-alkenyl-2,2'-bipyridine-6-carboxamide derivative |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |